Cited by 402Antimicrobial Peptides and ActivitiesAntimicrobial agents and applicationsProbiotics and Fermented Foods

The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.

Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance

Hassan, M., Kjos, M., Nes, I.F., Diep, D.B., Lotfipour, F.·2012·Journal of Applied Microbiology

DOI 10.1111/j.1365-2672.2012.05338.x

Open this paper in CoChat — free account

Abstract

Because of the emergence of antibiotic-resistant pathogens worldwide, a number of infectious diseases have become difficult to treat. This threatening situation is worsened by the fact that very limited progress has been made in developing new and potent antibiotics in recent years. However, a group of antimicrobials, the so-called bacteriocins, have been much studied lately because they hold a great potential in controlling antibiotic-resistant pathogens. Bacteriocins are small antimicrobial peptides (AMPs) produced by numerous bacteria. They often act toward species related to the producer with a very high potency (at pico- to nanomolar concentration) and specificity. The common mechanisms of killing by bacteriocins are destruction of target cells by pore formation and/or inhibition of cell wall synthesis. Several studies have revealed that bacteriocins display great potential in the medical sector as bacteriocinogenic probiotics and in the clinic as therapeutic agents. In this review, we discuss the emerging antibiotic resistance and strategies to control its dissemination, before we highlight the potential of AMPs from bacteria as a new genre of antimicrobial agents.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2672.2012.05338.x

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Bacteriocins of gram-positive bacteria
Jack, R. W., Tagg, J. R., & Ray, B. (1995) · Microbiological Reviews · doi:10.1128/mr.59.2.171-200.1995 · Cited by 2,711
Bacteriocins: Developing innate immunity for food
Cotter, P. D., Hill, C., & Ross, R. P. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1273 · Cited by 2,380
Phosphoenolpyruvate:carbohydrate phosphotransferase systems of bacteria
Postma, P. W., Lengeler, J. W., & Jacobson, G. R. (1993) · Microbiological Reviews · doi:10.1128/mr.57.3.543-594.1993 · Cited by 1,802
Probiotic bacteria enhance murine and human intestinal epithelial barrier function
Madsen, K., Cornish, A. S., Soper, P., McKaigney, C. J., Jijon, H. B., Yachimec, C., Doyle, J. S. G., Jewell, L. D., & Simone, C. D. (2001) · Gastroenterology · doi:10.1053/gast.2001.27224 · Cited by 1,096
Dendrimers in gene delivery
Dufès, C., Uchegbu, I. F., & Schätzlein, A. G. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.017 · Cited by 984
Trends in antimicrobial drug development: Implications for the future
Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/420937 · Cited by 867
Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118
Corr, S. C., Li, Y., Riedel, C. U., O'Toole, P. W., Hill, C., & Gahan, C. G. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700440104 · Cited by 853
Specific Binding of Nisin to the Peptidoglycan Precursor Lipid II Combines Pore Formation and Inhibition of Cell Wall Biosynthesis for Potent Antibiotic Activity
Wiedemann, I., Breukink, E. J., van Kraaij, C., Kuipers, O. P., Bierbaum, G., KRUIJFF, B. D., & Sahl, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006770200 · Cited by 793
Handbook of Biologically Active Peptides
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-369442-3.x5001-6 · Cited by 720
Bacteriocins from lactic acid bacteria: Production, purification, and food applications
De Vuyst, L., & Leroy, F. (2007) · Microbial Physiology · doi:10.1159/000104752 · Cited by 708
Lipid II as a target for antibiotics
Breukink, E. J., & KRUIJFF, B. D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2004 · Cited by 702
PHOSPHATE BOUND TO HISTIDINE IN A PROTEIN AS AN INTERMEDIATE IN A NOVEL PHOSPHO-TRANSFERASE SYSTEM
Kundig, W., Ghosh, S., & Roseman, S. (1964) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.52.4.1067 · Cited by 616
Antimicrobial peptides: General overview and clinical implications in human health and disease
Guaní-Guerra, E., Santos-Mendoza, T., Reyes, S. O. L., & Teran, L. M. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.12.004 · Cited by 571
The nisin–lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics
Hsu, S. D., Breukink, E. J., Tischenko, E., Lutters, M., KRUIJFF, B. D., Kaptein, R., Bonvin, A. M. J. J., & van Nuland, N. A. J. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb830 · Cited by 550
Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton–Valentine leukocidin
Boyle‐Vavra, S., & Daum, R. S. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700501 · Cited by 548
Lantibiotics: Mode of Action, Biosynthesis and Bioengineering
Bierbaum, G., & Sahl, H. (2009) · Current Pharmaceutical Biotechnology · doi:10.2174/138920109787048616 · Cited by 535
Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile
Rea, M. C., Sit, C. S., Clayton, E., O'Connor, P. M., Whittal, R. M., Zheng, J., Vederas, J. C., Ross, R. P., & Hill, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913554107 · Cited by 530
Phosphoenolpyruvate:carbohydrate phosphotransferase systems of bacteria.
Postma, P. W., Lengeler, J. W., & Jacobson, G. R. (1993) · Microbiological Reviews · doi:10.1128/mmbr.57.3.543-594.1993 · Cited by 511
An Alternative Bactericidal Mechanism of Action for Lantibiotic Peptides That Target Lipid II
Hasper, H. E., Kramer, N. E., Smith, L., Hillman, J. D., Zachariah, C., Kuipers, O. P., KRUIJFF, B. D., & Breukink, E. J. (2006) · Science · doi:10.1126/science.1129818 · Cited by 502
Dendrimers as Drug Carriers: Applications in Different Routes of Drug Administration
Cheng, Y., Xu, Z., Ma, M., & Xu, T. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21079 · Cited by 456
The Quinolones: Past, Present, and Future
Andriole, V. T. (2005) · Clinical Infectious Diseases · doi:10.1086/428051 · Cited by 428
Role of lipid‐bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics
Brötz, H., Josten, M., Wiedemann, I., Schneider, U., Götz, F., Bierbaum, G., & Sahl, H. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01065.x · Cited by 421
The dual role of bacteriocins as anti- and probiotics
Gillor, O., Etzion, A., & Riley, M. A. (2008) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-008-1726-5 · Cited by 418
Common mechanisms of target cell recognition and immunity for class II bacteriocins
Diep, D. B., Skaugen, M., Salehian, Z., Holo, H., & Nes, I. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608775104 · Cited by 393
Self-citation
Microcins, gene-encoded antibacterial peptides from enterobacteria
Duquesne, S., Destoumieux‐Garzón, D., Péduzzi, J., & Rebuffat, S. (2007) · Natural Product Reports · doi:10.1039/b516237h · Cited by 389
Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon
Rea, M. C., Dobson, A., O'Sullivan, O., Crispie, F., Fouhy, F., Cotter, P. D., Shanahan, F., Kiely, B., Hill, C., & Ross, R. P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001224107 · Cited by 377
The Lantibiotic Mersacidin Inhibits Peptidoglycan Synthesis by Targeting Lipid II
Brötz, H., Bierbaum, G., Leopold, K., Reynolds, P. E., & Sahl, H. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.154 · Cited by 376
Treatment of Clostridium difficile-associated disease: old therapies and new strategies
Aslam, S., Hamill, R. J., & Musher, D. M. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70215-2 · Cited by 365
Ribosomally synthesized antimicrobial peptides: their function, structure, biogenesis, and mechanism of action
Nissen-Meyer, J., & Nes, I. F. (1997) · Archives of Microbiology · doi:10.1007/s002030050418 · Cited by 358
Self-citation
Production of class II bacteriocins by lactic acid bacteria; an example of biological warfare and communication
Eijsink, V. G. H., Axelsson, L. T., Diep, D. B., Håvarstein, L. S., Holo, H., & Nes, I. F. (2002) · Antonie van Leeuwenhoek · doi:10.1023/a:1020582211262 · Cited by 352
Self-citation
Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin
Lubelski, J., Rink, R., Khusainov, R., Moll, G. N., & Kuipers, O. P. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7171-2 · Cited by 349
The Epidemiological Profile of Infections with Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter Species
Paterson, D. L. (2006) · Clinical Infectious Diseases · doi:10.1086/504476 · Cited by 342
Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria
Héchard, Y., & Sahl, H. (2002) · Biochimie · doi:10.1016/s0300-9084(02)01417-7 · Cited by 340
Microcin 25, a novel antimicrobial peptide produced by Escherichia coli
Salomón, R. A., & Farı́as, R. N. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.22.7428-7435.1992 · Cited by 336
Comparative Studies of Class IIa Bacteriocins of Lactic Acid Bacteria
Eijsink, V. G. H., Rødland, M. S., Middelhoven, P. H., Brurberg, M. B., & Nes, I. F. (1998) · Applied and Environmental Microbiology · doi:10.1128/aem.64.9.3275-3281.1998 · Cited by 324
Self-citation
Formation of D ‐alanyl‐lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes
Abachin, É., Poyart, C., Pellegrini, E., Milohanic, E., Fiedler, F., Berche, P., & Trieu‐Cuot, P. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02723.x · Cited by 315
Antagonistic Activity against Helicobacter Infection In Vitro and In Vivo by the Human Lactobacillus acidophilus Strain LB
Coconnier, M. H., Moal, V. L.-L., Hemery, E., & Servin, A. L. (1998) · Applied and Environmental Microbiology · doi:10.1128/aem.64.11.4573-4580.1998 · Cited by 315
Diagnosis and treatment of tuberculosis in children
Shingadia, D. V., & Novelli, V. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00771-0 · Cited by 302
Lysostaphin Disrupts Staphylococcus aureus and Staphylococcus epidermidis Biofilms on Artificial Surfaces
Wu, J. A., Kusuma, C. M., Mond, J. J., & Kokai‐Kun, J. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3407-3414.2003 · Cited by 288
Bacterial Lantibiotics: Strategies to Improve Therapeutic Potential
Cotter, P. D., Hill, C., & Ross, R. P. (2005) · Current Protein and Peptide Science · doi:10.2174/1389203053027584 · Cited by 274
Reduction of Carriage of EnterohemorrhagicEscherichia coliO157:H7 in Cattle by Inoculation with Probiotic Bacteria
Zhao, T., Doyle, M. P., Harmon, B. G., Brown, C. A., Mueller, P. O. E., & Parks, A. H. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.3.641-647.1998 · Cited by 269
Helicobacter pylori and Probiotics1,
Lesbros-Pantoflickova, D., Corthésy-Theulaz, I. E., & Blum, A. L. (2007) · Journal of Nutrition · doi:10.1093/jn/137.3.812s · Cited by 262
Bacteriocin Diversity in Streptococcus and Enterococcus
Nes, I. F., Diep, D. B., & Holo, H. (2006) · Journal of Bacteriology · doi:10.1128/jb.01254-06 · Cited by 258
Self-citation
The Impact of Probiotic on Gut Health
Collado, M. C., Isolauri, E., Salminen, S., & Sanz, Y. (2009) · Current Drug Metabolism · doi:10.2174/138920009787048437 · Cited by 251
Broad‐spectrum antimicrobial peptide resistance by MprF‐mediated aminoacylation and flipping of phospholipids
Ernst, C. M., & Peschel, A. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07576.x · Cited by 239
Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model
Kruszewska, D., Sahl, H., Bierbaum, G., Pag, U., Hynes, S. O., & Ljungh, Å. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh387 · Cited by 235
A Five-Strain Probiotic Combination Reduces Pathogen Shedding and Alleviates Disease Signs in Pigs Challenged with Salmonella enterica Serovar Typhimurium
Casey, P. G., Gardiner, G. E., Casey, G. D., Bradshaw, B., Lawlor, P. G., Lynch, P. B., Leonard, F. C., Stanton, C., Ross, R. P., Fitzgerald, G. F., et al. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01840-06 · Cited by 226
Sublancin is not a lantibiotic but an S-linked glycopeptide
Oman, T. J., Boettcher, J. M., Wang, H., Okalibe, X. N., & van der Donk, W. A. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.509 · Cited by 225
Antibiotics: Where did we go wrong?
Overbye, K. M., & Barrett, J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03285-4 · Cited by 223
The mode of action of the lantibiotic lacticin 3147 – a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II
Wiedemann, I., Böttiger, T., Bonelli, R. R., Wiese, A., Hagge, S. O., Gutsmann, T., Seydel, U., Deegan, L. H., Hill, C., Ross, R. P., et al. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05223.x · Cited by 222
The leader peptide of colicin V shares consensus sequences with leader peptides that are common among peptide bacteriocins produced by Gram-positive bacteria
Håvarstein, L. S., Holo, H., & Nes, I. F. (1994) · Microbiology · doi:10.1099/13500872-140-9-2383 · Cited by 217
Self-citation
Identification of Genetic Loci in Lactobacillus plantarum That Modulate the Immune Response of Dendritic Cells Using Comparative Genome Hybridization
Meijerink, M., van Hemert, S., Taverne, N., Wels, M., de Vos, P., Bron, P. A., Savelkoul, H. F. J., van Bilsen, J. H. M., Kleerebezem, M., & Wells, J. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010632 · Cited by 214
Identification of Lactobacillus plantarum genes modulating the cytokine response of human peripheral blood mononuclear cells
van Hemert, S., Meijerink, M., Molenaar, D., Bron, P. A., de Vos, P., Kleerebezem, M., Wells, J. M., & Marco, M. L. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-293 · Cited by 205
Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications
Bastos, M. D. C. D. F., Coutinho, B. G., & Coelho, M. L. V. (2010) · Pharmaceuticals · doi:10.3390/ph3041139 · Cited by 204
High-level resistance to class IIa bacteriocins is associated with one general mechanism in Listeria monocytogenes
Gravesen, A., Ramnath, M., Rechinger, K. B., Andersen, N., Jänsch, L., Héchard, Y., Hastings, J. W., & Knøchel, S. (2002) · Microbiology · doi:10.1099/00221287-148-8-2361 · Cited by 190
Function of Lactococcus lactis Nisin Immunity Genes nisI and nisFEG after Coordinated Expression in the Surrogate Host Bacillus subtilis
Stein, T. H., Heinzmann, S., Solovieva, I. M., & Entian, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207237200 · Cited by 184
Collagen-based Biomaterials
Ramshaw, J. A. M., Werkmeister, J. A., & Glattauer, V. (1996) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.1996.10647934 · Cited by 182
Country-to-Country Transfer of Patients and the Risk of Multi-Resistant Bacterial Infection
Rogers, B. A., Aminzadeh, Z., Hayashi, Y., & Paterson, D. L. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir273 · Cited by 182
A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species
Piper, C., Draper, L. A., Cotter, P. D., Ross, R. P., & Hill, C. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp221 · Cited by 174
Cysteine S -glycosylation, a new post-translational modification found in glycopeptide bacteriocins
Stepper, J., Shastri, S., Loo, T. S., Preston, J. C., Novák, P., Man, P., Moore, C. H., Havlı́ček, V., Patchett, M. L., & Norris, G. E. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.01.023 · Cited by 170
Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children
Cruchet, S., Obregón, M. C., Salazar, G., Diaz, E., & Gotteland, M. (2003) · Nutrition · doi:10.1016/s0899-9007(03)00109-6 · Cited by 168
BAGEL2: mining for bacteriocins in genomic data
de Jong, A., van Heel, A. J., Kok, J., & Kuipers, O. P. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq365 · Cited by 168
Introduction: Antibiotic Resistance
Walsh, & Wright, G. D. (2005) · Chemical Reviews · doi:10.1021/cr030100y · Cited by 167
Antibiotic Resistance
Wester, C. W., Durairaj, L., Evans, A. T., Schwartz, D. N., Husain, S., & Martinez, E. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.19.2210 · Cited by 165
Identification and Characterization of Two Novel Clostridial Bacteriocins, Circularin A and Closticin 574
Kemperman, R., Kuipers, A., Karsens, H. A., Nauta, A., Kuipers, O. P., & Kok, J. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.3.1589-1597.2003 · Cited by 162
Lysostaphin Cream Eradicates Staphylococcus aureus Nasal Colonization in a Cotton Rat Model
Kokai‐Kun, J. F., Walsh, S. M., Chanturiya, T., & Mond, J. J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1589-1597.2003 · Cited by 161
Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme
Reynolds, R. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh232 · Cited by 161
Colicins and Microcins: The Next Generation Antimicrobials
Gillor, O., Kirkup, B. C., & Riley, M. A. (2004) · Advances in applied microbiology · doi:10.1016/s0065-2164(04)54005-4 · Cited by 159
Three-Dimensional Structure of Leucocin A in Trifluoroethanol and Dodecylphosphocholine Micelles: Spatial Location of Residues Critical for Biological Activity in Type IIa Bacteriocins from Lactic Acid Bacteria ,
Gallagher, N. L. F., Sailer, M., Niemczura, W. P., Nakashima, T. T., Stiles, M. E., & Vederas, J. C. (1997) · Biochemistry · doi:10.1021/bi971263h · Cited by 158
Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent
Misselwitz, B., Schmitt‐Willich, H., Ebert, W., Frenzel, T., & Weinmann, H. (2001) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/bf02668094 · Cited by 158
Frequency of Bacteriocin Resistance Development and Associated Fitness Costs in Listeria monocytogenes
Gravesen, A., Axelsen, A.-M. J., da Silva, J. M., Hansen, T. B., & Knøchel, S. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.2.756-764.2002 · Cited by 156
Capacity of Human Nisin- and Pediocin-Producing Lactic Acid Bacteria To Reduce Intestinal Colonization by Vancomycin-Resistant Enterococci
Millette, M., Cornut, G., Dupont, C., Shareck, F., Archambault, D., & Lacroix, M. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.02150-07 · Cited by 153
Peptide-Lipid Huge Toroidal Pore, a New Antimicrobial Mechanism Mediated by a Lactococcal Bacteriocin, Lacticin Q
Yoneyama, F., Imura, Y., Ohno, K., Zendo, T., Nakayama, J., Matsuzaki, K., & Sonomoto, K. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00209-09 · Cited by 152
In vivo conversion of L-serine to D-alanine in a ribosomally synthesized polypeptide.
Skaugen, M., Nissen-Meyer, J., Jung, G., Stevanović, S., Sletten, K., Inger, C., Abildgaard, M., & Nes, I. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46966-9 · Cited by 147
Self-citation
Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model
Goldstein, B. P. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.2.277 · Cited by 142
Classification of Bacteriocins from Gram-Positive Bacteria
Rea, M. C., Ross, R. P., Cotter, P. D., & Hill, C. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7692-5_3 · Cited by 140
Target recognition, resistance, immunity and genome mining of class II bacteriocins from Gram-positive bacteria
Kjos, M., Borrero, J., Opsata, M., Birri, D. J., Holo, H., Cintas, L. M., Snipen, L. G., Hernández, P. E., Nes, I. F., & Diep, D. B. (2011) · Microbiology · doi:10.1099/mic.0.052571-0 · Cited by 138
Self-citation
The C-terminal Domain of Pediocin-like Antimicrobial Peptides (Class IIa Bacteriocins) Is Involved in Specific Recognition of the C-terminal Part of Cognate Immunity Proteins and in Determining the Antimicrobial Spectrum
Johnsen, L., Fimland, G., & Nissen-Meyer, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412712200 · Cited by 131
Mechanisms of Resistance to Bacteriocins Targeting the Mannose Phosphotransferase System
Kjos, M., Nes, I. F., & Diep, D. B. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.02602-10 · Cited by 129
Self-citation
Absence of a Putative Mannose-Specific Phosphotransferase System Enzyme IIAB Component in a Leucocin A-Resistant Strain of Listeria monocytogenes , as Shown by Two-Dimensional Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis
Ramnath, M., Beukes, M., Tamura, K., & Hastings, J. W. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.7.3098-3101.2000 · Cited by 128
An Extracellular Loop of the Mannose Phosphotransferase System Component IIC Is Responsible for Specific Targeting by Class IIa Bacteriocins
Kjos, M., Salehian, Z., Nes, I. F., & Diep, D. B. (2010) · Journal of Bacteriology · doi:10.1128/jb.00777-10 · Cited by 121
Self-citation
Cell-surface alterations in class IIa bacteriocin-resistant Listeria monocytogenes strains
Vadyvaloo, V., Arous, S., Gravesen, A., Héchard, Y., Chauhan-Haubrock, R., Hastings, J. W., & Rautenbach, M. (2004) · Microbiology · doi:10.1099/mic.0.27059-0 · Cited by 120
Membranes of Class IIa Bacteriocin-Resistant Listeria monocytogenes Cells Contain Increased Levels of Desaturated and Short-Acyl-Chain Phosphatidylglycerols
Vadyvaloo, V., Hastings, J. W., van der Merwe, M. J., & Rautenbach, M. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.11.5223-5230.2002 · Cited by 119
Class II one-peptide bacteriocins target a phylogenetically defined subgroup of mannose phosphotransferase systems on sensitive cells
Kjos, M., Nes, I. F., & Diep, D. B. (2009) · Microbiology · doi:10.1099/mic.0.030015-0 · Cited by 118
Self-citation
Transcriptome Analysis Reveals Mechanisms by Which Lactococcus lactis Acquires Nisin Resistance
Kramer, N. E., van Hijum, S. A. F. T., Knol, J., Kok, J., & Kuipers, O. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1753-1761.2006 · Cited by 116
The Abi Proteins and Their Involvement in Bacteriocin Self-Immunity
Kjos, M., Snipen, L. G., Salehian, Z., Nes, I. F., & Diep, D. B. (2010) · Journal of Bacteriology · doi:10.1128/jb.01553-09 · Cited by 115
Self-citation
Predominance of a bacteriocin-producing Lactobacillus salivarius component of a five-strain probiotic in the porcine ileum and effects on host immune phenotype
Walsh, M. C., Gardiner, G. E., Hart, O. M., Lawlor, P. G., Daly, M., Lynch, B., Richert, B. T., Radcliffe, J. S., Giblin, L., Hill, C., et al. (2008) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2008.00454.x · Cited by 115
Impact of selectedLactobacillusandBifidobacteriumspecies onListeria monocytogenesinfection and the mucosal immune response
Corr, S. C., Gahan, C. G. M., & Hill, C. (2007) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2007.00264.x · Cited by 114
Improved Pharmacokinetics and Reduced Antibody Reactivity of Lysostaphin Conjugated to Polyethylene Glycol
Walsh, S. M., Shah, A., & Mond, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.554-558.2003 · Cited by 112
Specific Interaction of the Unmodified Bacteriocin Lactococcin 972 with the Cell Wall Precursor Lipid II
Martı́nez, B., Böttiger, T., Schneider, T., Rodrı́guez, A., Sahl, H., & Wiedemann, I. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.00092-08 · Cited by 108
Ribosomally Synthesiszed Antimicrobial Peptides (Bacteriocins) in Lactic Acid Bacteria: A Review
Nes, I. F., Yoon, S.-S., & Diep, D. B. (2007) · Food Science and Biotechnology · Cited by 107
Self-citation
Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice
Kokai‐Kun, J. F., Chanturiya, T., & Mond, J. J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp145 · Cited by 104
Protection Against Staphylococcus aureus Mastitis in Dairy Cows Using a Bismuth-Based Teat Seal Containing the Bacteriocin, Lacticin 3147
Twomey, D. P., Wheelock, A. I., Flynn, J., Meaney, W. J., Hill, C., & Ross, R. P. (2000) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(00)75075-2 · Cited by 103
Isolation and characterization of microcin E 492 fromKlebsiella pneumoniae
de Lorenzo, V. (1984) · Archives of Microbiology · doi:10.1007/bf00692715 · Cited by 102
Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005
Finch, R., & Hunter, P. A. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl373 · Cited by 100
The effect of a mouthrinse based on nisin, a bacteriocin, on developing plaque and gingivitis in beagle dogs
Howell, T. H., Fiorellini, J. P., Blackburn, P., Projan, S. J., de la Harpe, J., & Williams, R. C. (1993) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.1993.tb00369.x · Cited by 95
In vivo activity of mutacin B-Ny266
Mota‐Meira, M., Morency, H., & Lavoie, M. C. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki295 · Cited by 94
Fundamental functionality: recent developments in understanding the structure–activity relationships of lantibiotic peptides
Ross, A. C., & Vederas, J. C. (2010) · The Journal of Antibiotics · doi:10.1038/ja.2010.136 · Cited by 92
Increased Antibiotic Resistance in Respiratory Tract Pathogens: PROTEKT US—An Update
Karchmer, A. W. (2004) · Clinical Infectious Diseases · doi:10.1086/421352 · Cited by 89
Microcin H47, a chromosome-encoded microcin antibiotic of Escherichia coli
Laviña, M. D., Gaggero, C., & Moreno, F. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.11.6585-6588.1990 · Cited by 87
An engineered multidomain bactericidal peptide as a model for targeted antibiotics against specific bacteria
Qiu, X., Wang, H., Lu, X.-F., Zhang, J., Li, S., Cheng, G., Wan, L., Yang, L., Zuo, J.-Y., Zhou, Y., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt913 · Cited by 87
pbp2229 -Mediated Nisin Resistance Mechanism in Listeria monocytogenes Confers Cross-Protection to Class IIa Bacteriocins and Affects Virulence Gene Expression
Gravesen, A., Kallipolitis, B. H., Holmstrøm, K., Høiby, P. E., Ramnath, M., & Knøchel, S. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.3.1669-1679.2004 · Cited by 86
Lantibiotic Immunity
Hill, C., Draper, L. A., Ross, R. P., & Cotter, P. D. (2008) · Current Protein and Peptide Science · doi:10.2174/138920308783565750 · Cited by 86
Efficacy of microcin J25 in biomatrices and in a mouse model of Salmonella infection
López, F. E., Vincent, P. A., Zenoff, A. M., Salomón, R. A., & Farı́as, R. N. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm009 · Cited by 84
Research advances in the development of peptide antibiotics
Rossi, L., Rangasamy, P., Zhang, J., Qiu, X., & Wu, G. Y. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21053 · Cited by 80
Cloning and mapping of the genetic determinants for microcin C7 production and immunity
Novoa, M. A., Díaz-Guerra, L., Millán, J. L. S., & Moreno, F. (1986) · Journal of Bacteriology · doi:10.1128/jb.168.3.1384-1391.1986 · Cited by 78
Lysostaphin-Coated Catheters Eradicate Staphylococccus aureus Challenge and Block Surface Colonization
Shah, A., Mond, J., & Walsh, S. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2704-2707.2004 · Cited by 77
Characterization of a New Operon,as-48EFGH, from theas-48Gene Cluster Involved in Immunity to Enterocin AS-48
Diaz, M., Valdivia, E., Martínez‐Bueno, M., Fernández, M., Soler‐González, A. S., Ramírez-Rodrigo, H., & Maqueda, M. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.2.1229-1236.2003 · Cited by 76
Class IIa bacteriocin resistance in Enterococcus faecalis V583: The mannose PTS operon mediates global transcriptional responses
Opsata, M., Nes, I. F., & Holo, H. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-224 · Cited by 76
Self-citation
Therapeutic potential of type A (I) lantibiotics, a group of cationic peptide antibiotics
Smith, L., & Hillman, J. D. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.09.008 · Cited by 74
Ethical dilemmas in antibiotic treatment
Leibovici, L., Paul, M., & Ezra, O. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr425 · Cited by 69
Lacticin Q, a Lactococcal Bacteriocin, Causes High-Level Membrane Permeability in the Absence of Specific Receptors
Yoneyama, F., Imura, Y., Ichimasa, S., Fujita, K., Zendo, T., Nakayama, J., Matsuzaki, K., & Sonomoto, K. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.01827-08 · Cited by 63
Complex Phenotypic and Genotypic Responses of Listeria monocytogenes Strains Exposed to the Class IIa Bacteriocin Sakacin P
Tessema, G. T., Møretrø, T., Köhler, A., Axelsson, L. T., & Naterstad, K. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.00608-09 · Cited by 61
Prescription for an ailing pharmaceutical industry
Demain, A. L. (2002) · Nature Biotechnology · doi:10.1038/nbt0402-331 · Cited by 58
Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies.
Schaffner, W., Melly, M. A., Hash, J. H., & Koenig, M. (1967) · PubMed Central · Cited by 57
Growing insights into the safety of bacteriocins: the case of enterocin S37
Belguesmia, Y., Madi, A., Spérandio, D., Mérieau, A., Feuilloley, M. G. J., Prévost, H., Drider, D., & Connil, N. (2010) · Research in Microbiology · doi:10.1016/j.resmic.2010.09.019 · Cited by 55
Three-Dimensional Structure in Lipid Micelles of the Pediocin-like Antimicrobial Peptide Curvacin A,
Haugen, H. S., Fimland, G., Nissen-Meyer, J., & Kristiansen, P. E. (2005) · Biochemistry · doi:10.1021/bi051215u · Cited by 52
Perceptions of hand hygiene practices in China
Yuan, C. T., Dembry, L., Higa, B., Fu, M., Wang, H., & Bradley, E. H. (2008) · Journal of Hospital Infection · doi:10.1016/j.jhin.2008.09.017 · Cited by 51
Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit.
Dajcs, J. J., Thibodeaux, B. A., Girgis, D. O., Shaffer, M. D., Delvisco, S. M., & O’Callaghan, R. J. (2002) · PubMed · Cited by 47
Lysostaphin: Model for a Specific Enzymatic Approach to Infectious Disease
Zygmunt, W. A., & Tavormina, P. A. (1972) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7081-8_7 · Cited by 45
Development of drugs for antimicrobial-resistant pathogens
Powers, J. H. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200312000-00006 · Cited by 41
A Novel Engineered Peptide, a Narrow-Spectrum Antibiotic, is Effective against Vancomycin-Resistant Enterococcus faecalis
Qiu, X., Zhang, J., Wang, H., & Wu, G. Y. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1184-1189.2005 · Cited by 41
Potent, synergistic inhibition of Staphylococcus aureus upon exposure to a combination of the endopeptidase lysostaphin and the cationic peptide ranalexin
Graham, S., & Coote, P. J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl539 · Cited by 39
Potential impact of rapid diagnostic tests on improving antimicrobial use
Tenover, F. C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05827.x · Cited by 34
In vitro activity of recombinant lysostaphin-antibiotic combinations toward methicillin-resistant Staphylococcus aureus
Polak, J., Latta, P. D., & Blackburn, P. (1993) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(93)90034-5 · Cited by 34
Expression of the lysostaphin gene of Staphylococcus simulans in a eukaryotic system
Williamson, C., Bramley, A. J., & Lax, A. J. (1994) · Applied and Environmental Microbiology · doi:10.1128/aem.60.3.771-776.1994 · Cited by 28
NISIN IN EXPERIMENTAL TUBERCULOSIS
Bavin, E. M., Beach, A. S., Falconer, R., & Friedmann, R. (1952) · The Lancet · doi:10.1016/s0140-6736(52)92429-x · Cited by 28
Dendritic Poly(ether imine) Based Gene Delivery Vector
Ullas, P. T., Madhusudana, S. N., Desai, A. S., Jayamurugan, G., Yamajala, R. B. R. D., & Jayaraman, N. (2010) · Bioconjugate Chemistry · doi:10.1021/bc1003108 · Cited by 26
Lysostaphin: an enzymatic approach to staphylococcal disease. 3. Combined lysostaphin-methicillin therapy of established staphylococcal abscesses in mice.
Dixon, R., Goodman, J. S., & Koenig, M. G. (1968) · PubMed · Cited by 26
Amphiphilic Dendrimeric Peptides as Model Non-Sequential Pharmacophores with Antimicrobial Properties
Janiszewska, J., & Urbańczyk-Lipkowska, Z. (2007) · Microbial Physiology · doi:10.1159/000104751 · Cited by 24
Antibiotic Resistance: The Pandemic
Verhoef, J. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0059-9_26 · Cited by 23
The Lcn972 Bacteriocin-Encoding Plasmid pBL1 Impairs Cellobiose Metabolism in Lactococcus lactis
Campelo, A. B., Gaspar, P., Roces, C., Rodrı́guez, A., Kok, J., Kuipers, O. P., Neves, A. R., & Martı́nez, B. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.06107-11 · Cited by 22
Lysostaphin in Experimental Renal Infections
Harrison, E. F., & Zygmunt, W. A. (1967) · Journal of Bacteriology · doi:10.1128/jb.93.2.520-524.1967 · Cited by 17
Lantibiotic Production by Pathogenic Microorganisms
Daly, K. M., Cotter, P. D., Hill, C., & Ross, R. P. (2012) · Current Protein and Peptide Science · doi:10.2174/138920312803582997 · Cited by 15
Paralogous genes encoding transport proteins in microbial genomes
Saier, M. H., & Paulsen, I. T. (1999) · Research in Microbiology · doi:10.1016/s0923-2508(99)00123-0 · Cited by 13

Research works printed but not linked: 2

Bonelli, 2006, Lantibiotics, including nisin, 1139
Rea, 2010b, Microbes and Health Sackler Colloquium: effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon, Proc Natl Acad Sci USA, 15, 4639

Sorted by citations

Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 2,020
Probiotic Mechanisms of Action
Bermúdez-Brito, M., Plaza‐Díaz, J., Muñoz‐Quezada, S., Gómez‐Llorente, C., & Gil, Á. (2012) · Annals of Nutrition and Metabolism · doi:10.1159/000342079 · Cited by 1,326
Bacteriocins, Antimicrobial Peptides from Bacterial Origin: Overview of Their Biology and Their Impact against Multidrug-Resistant Bacteria
Simons, A., Alhanout, K., & Duval, R. E. (2020) · Microorganisms · doi:10.3390/microorganisms8050639 · Cited by 587
Escherichia coli in Europe: An Overview
Allocati, N., Masulli, M., ALEXEYEV, M. F., & Ilio, C. D. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10126235 · Cited by 481
Antimicrobial peptides (AMPs): A promising class of antimicrobial compounds
Büyükkiraz, M. E., & Kesmen, Z. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.15314 · Cited by 457

See all 402

Authors: Hassan, M., Kjos, M., Nes, I. F., Diep, D. B., & Lotfipour, F.
Affiliations: Zanjan University of Medical Sciences (IR)
Norwegian University of Life Sciences (NO)
Tabriz University of Medical Sciences (IR)
Corresponding author: Lotfipour, F.
ORCID: Hassan, M.
Kjos, M.
Diep, D.B.
Lotfipour, F.
Venue: Journal of Applied Microbiology
Publisher: Oxford University Press (OUP)
Published: 2012-06-08
Volume: 113
Issue: 4
Pages: 723-736
ISSN: 1364-5072 (ISSN-L)
DOI: 10.1111/j.1365-2672.2012.05338.x
OpenAlex: W2132437761
Cited by: 402
References: 135
Citations by year: 2026: 13 · 2025: 19 · 2024: 32 · 2023: 32 · 2022: 42 · 2021: 35 · 2020: 45 · 2019: 34 · 2018: 29 · 2017: 29 · 2016: 23 · 2015: 28 · 2014: 21 · 2013: 13 · 2012: 7
FWCI: 3.19
Type: journal article
Language: en
Open access: closed
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 1180 d)
Locations: Journal of Applied Microbiology (publishedVersion)
PubMed (publishedVersion)
Funders: World Health Organization
National Institute of Allergy and Infectious Diseases
Topics: Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antimicrobial agents and applications
Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords: antimicrobial peptides, bacteriocins, antibiotic resistance, antibiotic-resistant pathogens, pore formation, cell wall synthesis inhibition, natural antimicrobials
MeSH terms: Bacteria, Bacteriocins, Peptides, Probiotics, Drug Resistance, Bacterial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks